Atlas Trials

Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia

Clinical trial NCT01845727 · COMPLETED

Trial details

NCT number
NCT01845727
Sponsor
Drugs for Neglected Diseases
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cutaneous Leishmaniasis
Start date
2014-02-01
Primary completion
2016-05-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.